BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 23157855)

  • 1. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.
    Conde-Agudelo A; Romero R; Nicolaides K; Chaiworapongsa T; O'Brien JM; Cetingoz E; da Fonseca E; Creasy G; Soma-Pillay P; Fusey S; Cam C; Alfirevic Z; Hassan SS
    Am J Obstet Gynecol; 2013 Jan; 208(1):42.e1-42.e18. PubMed ID: 23157855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of SuPPoRT: a multi-centre randomised controlled trial to compare three treatments: cervical cerclage, cervical pessary and vaginal progesterone, for the prevention of preterm birth in women who develop a short cervix.
    Hezelgrave NL; Watson HA; Ridout A; Diab F; Seed PT; Chin-Smith E; Tribe RM; Shennan AH
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):358. PubMed ID: 27871275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
    Romero R; Nicolaides KH; Conde-Agudelo A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Hassan SS
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
    Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M
    Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Nicolaides KH
    Am J Obstet Gynecol; 2018 Feb; 218(2):161-180. PubMed ID: 29157866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix.
    Alfirevic Z; Owen J; Carreras Moratonas E; Sharp AN; Szychowski JM; Goya M
    Ultrasound Obstet Gynecol; 2013 Feb; 41(2):146-51. PubMed ID: 22991337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerclage versus vaginal progesterone in low-risk pregnant women with a short cervix.
    Martinez O; Moran HK; Wolff SF; Gibbs C; Lee G; Gorman K; Martin A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9878-9883. PubMed ID: 35440280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy.
    Alfirevic Z; Stampalija T; Medley N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD008991. PubMed ID: 28586127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies.
    Eleje GU; Eke AC; Ikechebelu JI; Ezebialu IU; Okam PC; Ilika CP
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012871. PubMed ID: 32970845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis.
    Berghella V; Rafael TJ; Szychowski JM; Rust OA; Owen J
    Obstet Gynecol; 2011 Mar; 117(3):663-671. PubMed ID: 21446209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of follow-up cervical length screening in low-risk women with a cervical length of 26 to 29 mm.
    Boelig RC; Kripalu V; Chen SL; Cruz Y; Roman A; Berghella V
    Am J Obstet Gynecol; 2021 Aug; 225(2):179.e1-179.e6. PubMed ID: 33652056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R; Rehal A; Brizot ML; Serra V; Da Fonseca E; Cetingoz E; Syngelaki A; Perales A; Hassan SS; Nicolaides KH
    Am J Obstet Gynecol; 2023 Dec; 229(6):599-616.e3. PubMed ID: 37196896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks' gestation: open label, multicentre, randomised, controlled trial.
    van Dijk CE; van Gils AL; van Zijl MD; Koullali B; van der Weide MC; van den Akker ES; Hermsen BJ; van Baal WM; Visser H; van Drongelen J; Vollebregt KC; Muller M; van der Made FW; Gordijn SJ; de Mooij YM; Oudijk MA; de Boer MA; Mol BW; Kazemier BM; Pajkrt E;
    BMJ; 2024 Mar; 384():e077033. PubMed ID: 38471724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis.
    Jarde A; Lutsiv O; Beyene J; McDonald SD
    BJOG; 2019 Apr; 126(5):556-567. PubMed ID: 30480871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
    Cheung KW; Seto MTY; Ng EHY
    Trials; 2020 Jan; 21(1):121. PubMed ID: 32000820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.